• 1
    Kloosterboer HJ. Tibolone: a steroid with a tissue-specific mode of action. J Steroid Biochem Mol Biol 2001;76: 231238.
  • 2
    Moore RA. Livial: a review of clinical studies. Br J Obstet Gynaecol 1999;106(Suppl 19):121.
  • 3
    Egarter C, Huber J, Leikermoser R, et al. Tibolone versus conjugated estrogens and sequential progestogen in the treatment of climacteric complaints. Maturitas 1996;23: 5562.
  • 4
    Siseles NO, Halperin H, Benencia HJ, et al. A comparative study of two hormone replacement therapy regimens on safety and efficacy variables. Maturitas 1995;21: 201210.
  • 5
    Crona N, Samsioe G, Lindberg U-B, Silfverstolpe G. Treatment of climacteric complaints with Org OD 14. Comparative study with oestradiol valerate and placebo. Maturitas 1988;9: 303308.
  • 6
    Hammar M, Christau S, Nathorst-Böös J, Rud T, Garre K. A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms. Br J Obstet Gynaecol 1998;105: 904911.
  • 7
    Bjarnason NH, Bjarnason K, Haarbo J, Rosenquist C, Christiansen C. Tibolone: prevention of bone loss in late postmenopausal women. J Clin Endocrinol Metab 1996;81: 24192422.
  • 8
    Berning B, Kuijk C van, Kuiper JW, Coelingh Bennink HJT, Kicovic PM, Fauser BCJM. Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study. Bone 1996;19: 395399.
  • 9
    Gallagher JC, Baylink DJ, Freeman R, McClung M. Prevention of bone loss with tibolone in postmenopausal women: results of two randomized, double-blind, placebo-controlled, dose finding studies. J Clin Endocrinol Metab 2001;86: 47174726.
  • 10
    Archer DF, Pickar JH, Bottiglioni F, for the Menopause Study Group. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Obstet Gynecol 1994;83: 686692.
  • 11
    Archer DF, Dorin M, Lewis V, Schneider DL, Pickar JH. Effect of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding. Fertil Steril 2001;75: 10801087.
  • 12
    Lindsay R, Hart DM, Kraszewski A. A prospective, double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. BMJ 1980;280: 12071209.